Results 31 to 40 of about 126,591 (208)

Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion

open access: yesTrials, 2022
Introduction Malignant pleural effusions (MPEs) are common. MPE causes significant breathlessness and impairs quality of life. Indwelling pleural catheters (IPC) allow ambulatory drainage and reduce hospital days and re-intervention rates when compared ...
Deirdre B. Fitzgerald   +24 more
doaj   +1 more source

The efficacy of indwelling pleural catheter placement versus placement plus talc sclerosant in patients with malignant pleural effusions managed exclusively as outpatients (IPC-PLUS): study protocol for a randomised controlled trial [PDF]

open access: yes, 2015
BACKGROUND: Malignant pleural effusions (MPEs) remain a common problem, with 40,000 new cases in the United Kingdom each year and up to 250,000 in the United States.
Bhatnagar, R   +6 more
core   +5 more sources

Chest ultrasonography to assess the kinetics and efficacy of talc pleurodesis in a model of pneumothorax: an experimental animal study

open access: yesERJ Open Research, 2018
Talc pleurodesis is used to avoid recurrences in malignant pleural effusions or pneumothorax. The lack of lung sliding detected by chest ultrasonography (CUS) after talc application is indicative of the effectiveness of pleurodesis.
Rachid Tazi-Mezalek   +10 more
doaj   +1 more source

Malignant Pleural Effusion: Palliative Managements and Indication for Pleurodesis Based on Survival Scores. [PDF]

open access: yesJ Surg Oncol
ABSTRACT Neoplastic pleural effusion is one in which malignant neoplastic cells are detected in the pleural fluid or in the parietal pleura. When secondary, it confirms disseminated neoplastic disease and suggests a reduced life expectancy and low quality of life.
de Avila Carvalho E   +9 more
europepmc   +2 more sources

Protocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis [PDF]

open access: yes, 2014
INTRODUCTION: Malignant pleural effusion can complicate most cancers. It causes breathlessness and requires hospitalisation for invasive pleural drainages. Malignant effusions often herald advanced cancers and limited prognosis.
Bint, M   +15 more
core   +1 more source

Management of malignant pleural effusion in Italian clinical practice: a nationwide survey

open access: yesBMC Pulmonary Medicine, 2023
Background Pleural disease (PD), particularly malignant pleural effusion (MPE), is a common cause of hospital admission and its prevalence is rising worldwide.
Federico Mei   +12 more
doaj   +1 more source

The modern diagnosis and management of pleural effusions [PDF]

open access: yes, 2015
A pleural effusion describes an excess of fluid in the pleural cavity, usually resulting from an imbalance in the normal rate of pleural fluid production or absorption, or both.
Bhatnagar, Rahul, Maskell, Nick A
core   +2 more sources

Pneumotórax espontâneo num pulmão vicariante

open access: yesRevista Portuguesa de Pneumologia, 2007
Resumo: O pneumotórax contralateral após pneumonectomia é uma situação rara. É necessário um alto índice de suspeição para um correcto diagnóstico, na ausência de exames complementares de diagnóstico. O trata-mento é um desafio, uma vez que
Anabela Marinho   +5 more
doaj   +1 more source

Therapeutic Medical Thoracoscopy

open access: yesMonaldi Archives for Chest Disease, 2015
-
P.A. Mori, A.G. Casalini
doaj   +1 more source

Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials [PDF]

open access: yes, 2014
Background Blinded outcome assessment is recommended in open-label trials to reduce bias, however it is not always feasible. It is therefore important to find other means of reducing bias in these scenarios.
A Dechartres   +29 more
core   +2 more sources

Home - About - Disclaimer - Privacy